04:11 PM EDT, 07/30/2024 (MT Newswires) -- Microsoft ( MSFT ) reported fiscal Q4 diluted earnings late Tuesday of $2.95 per share, up from $2.69 a year earlier. Analysts polled by Capital IQ expected $2.93. Revenue for the quarter ended June 30 was $64.73 billion, up from $56.19 billion a year earlier. Analysts polled by Capital IQ expected $64.44 billion....

(Reuters) - Starbucks ( SBUX ) reported a bigger-than-expected drop in third-quarter comparable sales on Tuesday, dragged by stubbornly weak demand in the U.S. and a 14% drop in its second-biggest market, China. The coffee chain's global comparable sales fell 3% in the quarter, compared with a 2.35% decline expected on average by analysts, according to LSEG data. However, Starbucks...

04:08 PM EDT, 07/30/2024 (MT Newswires) -- First Solar ( FSLR ) reported Q2 earnings late Tuesday of $3.25 per diluted share, up from $1.59 a year earlier. Analysts polled by Capital IQ expected $2.71. Net sales for the quarter that ended June 30 was $1.01 billion, up from $810.7 million a year earlier. Analysts surveyed by Capital IQ expected...

July 29 (Reuters) - Sanofi-owned biotech company Genzyme has sued rival Sarepta Therapeutics ( SRPT ) in Delaware federal court for allegedly infringing two patents related to Sarepta's Duchenne muscular dystrophy (DMD) treatment Elevidys. Genzyme said in the lawsuit, made public on Monday, that Sarepta mimics Genzyme's technology for modifying viruses used to deliver genes into human cells in gene-therapy...